We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.3B
AUM Growth
-$128M
Cap. Flow
-$697M
Cap. Flow %
-6.16%
Top 10 Hldgs %
41.41%
Holding
1,243
New
52
Increased
320
Reduced
317
Closed
40

Sector Composition

Rank Sector Weight
1 Real Estate 72.31%
2 Technology 4.13%
3 Industrials 3.02%
4 Financials 2.93%
5 Healthcare 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIGL icon
1126
Rigel Pharmaceuticals
RIGL
$680M
$2K ﹤0.01%
81
SLDB icon
1127
Solid Biosciences
SLDB
$771M
$2K ﹤0.01%
20
SYBX
1128
DELISTED
Synlogic
SYBX
$2K ﹤0.01%
11
XENE icon
1129
Xenon Pharmaceuticals
XENE
$6.32B
$2K ﹤0.01%
165
XERS icon
1130
Xeris Biopharma Holdings
XERS
$1.44B
$2K ﹤0.01%
170
TECX
1131
Tectonic Therapeutic
TECX
$573M
$2K ﹤0.01%
13
SYRS
1132
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2K ﹤0.01%
22
IMGN
1133
DELISTED
Immunogen Inc
IMGN
$2K ﹤0.01%
731
AMRS
1134
DELISTED
Amyris Inc.
AMRS
$2K ﹤0.01%
499
ACOR
1135
DELISTED
Acorda Therapeutics
ACOR
$2K ﹤0.01%
2
CNCE
1136
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2K ﹤0.01%
126
ELOX
1137
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$2K ﹤0.01%
6
AMAG
1138
DELISTED
AMAG Pharmaceuticals
AMAG
$2K ﹤0.01%
195
FTSV
1139
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$2K ﹤0.01%
198
ACHN
1140
DELISTED
Achillion Pharmaceuticals
ACHN
$2K ﹤0.01%
762
DOVA
1141
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$2K ﹤0.01%
142
ABUS icon
1142
Arbutus Biopharma
ABUS
$865M
$1K ﹤0.01%
304
ADAP
1143
DELISTED
Adaptimmune Therapeutics
ADAP
$1K ﹤0.01%
323
AQST icon
1144
Aquestive Therapeutics
AQST
$462M
$1K ﹤0.01%
163
ASRT
1145
DELISTED
Assertio
ASRT
$1K ﹤0.01%
6
COGT icon
1146
Cogent Biosciences
COGT
$6.79B
$1K ﹤0.01%
49
DBVT
1147
DBV Technologies
DBVT
$807M
$1K ﹤0.01%
13
EYPT icon
1148
EyePoint Inc
EYPT
$1.02B
$1K ﹤0.01%
62
FBRX icon
1149
Forte Biosciences
FBRX
$1.12B
0
GERN icon
1150
Geron
GERN
$911M
$1K ﹤0.01%
880

Similar funds

Daiwa Securities Group's Q2 2019 Portfolio in Review

As of Q2 2019, Daiwa Securities Group held 1,243 positions worth $11.3B, down 1.1% from $11.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group withdrew a net $697M in Q2 2019, closing 40 positions and reducing 317 holdings. Its most notable exit was L3Harris, an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 74% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Coupa Software Incorporated worth $4.17M.

  • Daiwa Securities Group's largest Q2 2019 buy was Coupa Software Incorporated: 32,900 shares worth $4.17M.
  • Daiwa Securities Group added most to Host Hotels & Resorts in Q2 2019, an estimated $98.9M increase.
  • Daiwa Securities Group's biggest Q2 2019 reduction was Digital Realty Trust, cutting an estimated $144M.
  • Daiwa Securities Group fully exited L3Harris in Q2 2019, selling an estimated $3.77M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $11.3B portfolio in Q2 2019.
  • Daiwa Securities Group opened 52 new positions and closed 40 in Q2 2019.
  • Daiwa Securities Group's portfolio value fell 1.1% quarter-over-quarter to $11.3B.

Based on Daiwa Securities Group's 13F filing for Q2 2019, filed 24 Jul 2019.